- Home
- PFO vs NSPR Comparison
PFO vs NSPR Comparison
Compare PFO & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFO
- NSPR
- Stock Information
- Founded
- PFO 1991
- NSPR 2005
- Country
- PFO United States
- NSPR United States
- Employees
- PFO N/A
- NSPR N/A
- Industry
- PFO Finance Companies
- NSPR Medical/Dental Instruments
- Sector
- PFO Finance
- NSPR Health Care
- Exchange
- PFO Nasdaq
- NSPR Nasdaq
- Market Cap
- PFO 121.4M
- NSPR 101.8M
- IPO Year
- PFO N/A
- NSPR N/A
- Fundamental
- Price
- PFO $9.73
- NSPR $2.41
- Analyst Decision
- PFO
- NSPR Strong Buy
- Analyst Count
- PFO 0
- NSPR 2
- Target Price
- PFO N/A
- NSPR $4.50
- AVG Volume (30 Days)
- PFO 31.8K
- NSPR 78.7K
- Earning Date
- PFO 01-01-0001
- NSPR 11-11-2025
- Dividend Yield
- PFO 6.51%
- NSPR N/A
- EPS Growth
- PFO N/A
- NSPR N/A
- EPS
- PFO N/A
- NSPR N/A
- Revenue
- PFO N/A
- NSPR $7,066,000.00
- Revenue This Year
- PFO N/A
- NSPR $7.48
- Revenue Next Year
- PFO N/A
- NSPR $104.39
- P/E Ratio
- PFO N/A
- NSPR N/A
- Revenue Growth
- PFO N/A
- NSPR 7.60
- 52 Week Low
- PFO $6.90
- NSPR $1.99
- 52 Week High
- PFO $8.51
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- PFO 85.98
- NSPR 47.99
- Support Level
- PFO $9.40
- NSPR $2.37
- Resistance Level
- PFO $9.31
- NSPR $2.45
- Average True Range (ATR)
- PFO 0.06
- NSPR 0.07
- MACD
- PFO 0.03
- NSPR -0.00
- Stochastic Oscillator
- PFO 100.00
- NSPR 37.50
About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated
Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.